Abstract: In this paper, we focus on the development and manufacturing of a vaccine to combat the COVID-19. COVID-19 vaccine has been considered by many specialists as the best strategy to face the pandemic. Developing a safe and effective vaccine to combat COVID-19 in a timely manner is as daunting as scaling-up manufacturing to produce billions of doses. To accomplish such a goal, pharmaceutical companies have to prepare themselves in terms of infrastructure to ramp-up production as quickly as possible. One potential alternative to do that is to build ...
(read more)
Topics: 
Risk analysis (engineering)